Top

Journal of Assisted Reproduction and Genetics

Published in:

01-12-2011 | Fertility Preservation

Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing

Authors: Clara González, Marta Devesa, Montserrat Boada, Buenaventura Coroleu, Anna Veiga, Pere N. Barri

Published in: Journal of Assisted Reproduction and Genetics | Issue 12/2011

Excerpt

Breast cancer is the most common malignancy in women and nearly 7% of cases are diagnosed before age 40 [1]. Diagnosis at early ages is associated with a worse prognosis and therefore, these cases are usually managed with adjuvant chemotherapy and/or hormonal therapy. These treatments are effective in reducing recurrence rates and improving survival rates; however, they have a negative impact on ovarian function and fertility [2]. Fertility preservation in these cases may be of interest also due to the current trend towards delaying motherhood, which leads to a situation where many women may have not fulfilled their motherhood desire at the time of breast cancer diagnosis. …

Dunn L, Fox KR. Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol. 2009;21:68–73.PubMedCrossRef

Hickey M, Peate M, Saunders CM, Friedlander M. Breast cancer in young women and its impact on reproductive function. Hum Reprod Update. 2009;15:323–39.PubMedCrossRef

Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: The Cryo Top method. Theriogenology. 2007;67:73–80.PubMedCrossRef

Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans MM. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update. 2006;12:519–35.PubMedCrossRef

Cruz MRS, Prestes JC, Gimenes DL, Fanelli MF. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil Steril. 2010;94:138–43.PubMedCrossRef

Maltaris T, Weigel M, Mueller A, Schmidt M, Seufert R, Fischl F, et al. Cancer and fertility preservation: fertility preservation in breast cancer patients. Breast Cancer Res. 2008;10:206.PubMedCrossRef

Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.PubMedCrossRef

Demirtas E, Elizur SE, Holzer H, Gidoni Y, Son WY, Chian RC, et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online. 2008;17:520–3.PubMedCrossRef

Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391–8.PubMedCrossRef

10.

Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med. 2011;29:24–37.PubMedCrossRef

11.

Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online. 2010;20:634–8.PubMedCrossRef

12.

Rosendahl M, Timmermans Wielenga V, Nedergaard L, Kristensen SG, Ernst E, Rasmussen PE, et al. Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril. 2011;95:2158–61.PubMedCrossRef

13.

Schattman GL, Navarro J. Breast cancer and fertility preservation. Placenta. 2008;29:147–51.PubMedCrossRef

14.

Borini A, Rebellato E. Focus on breast and ovarian cancer. Placenta. 2008;29:184–90.PubMedCrossRef

15.

Donnez J, Dolmans MM. Preservation of fertility in females with haematological malignancy. Br J Haematol. 2011;154:175–84.PubMedCrossRef

16.

Donnez J, Kim SS, Albertini DF. Proceedings of the First World Congress on Fertility Preservation: executive summary. J Assist Reprod Genet. 2010;27:191–5.PubMedCrossRef

17.

Kim SS. Time to re-think: ovarian tissue transplantation versus whole ovary transplantation. Reprod Biomed Online. 2010;20:171–4.PubMedCrossRef

18.

Telfer EE, McLaughlin M. In vitro development of ovarian follicles. Semin Reprod Med. 2011;29:15–23.PubMedCrossRef

19.

Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008;89:567–72.PubMedCrossRef

20.

Huang JY, Tulandi T, Holzer H, Lau NM, Macdonald S, Tan SL, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report. Hum Reprod. 2008;23:336–9.PubMedCrossRef

Title: Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing
Authors: Clara González
Marta Devesa
Montserrat Boada
Buenaventura Coroleu
Anna Veiga
Pere N. Barri
Publication date: 01-12-2011
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 12/2011
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-011-9628-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2011

Maturation outcomes are improved following Cryoleaf vitrification of immature human oocytes when compared to choline-based slow-freezing

Viability assessment of fresh and frozen/thawed isolated human follicles: reliability of two methods (Trypan blue and Calcein AM/ethidium homodimer-1)

Impact of freezing and thawing of human ovarian tissue on follicular growth after long-term xenotransplantation

Implantation rates of embryos generated from slow cooled human oocytes from young women are comparable to those of fresh and frozen embryos from the same age group

ART, birth defects and subfertility—what should prospective patients be told?

Early cumulus cell removal could reduce the available embryo rate in human IVF